Entry inhibitor | Concentration | Continuousa | Withdrawal |
---|
CPEb | p24 | CPE | p24 |
---|
DS 003 | 2 nM | 3/3c | >600Â ng/mld | 3/3 | >600Â ng/mld |
20 nM | 1/3 | variable | 3/3 | >600Â ng/ml |
200 nM | 1/3 | variable | 3/3 | >600Â ng/ml |
AMD3100 | 0.18 μM | 3/3 | >600 ng/ml | 3/3 | >600 ng/ml |
18 μM | 1/3 | variable | 3/3 | >600 ng/ml |
180 μM | 1/3 | variable | 3/3 | >600 ng/ml |
Maraviroc | 1.0 nM | 3/3 | >600Â ng/ml | 3/3 | >600Â ng/ml |
10 nM | 3/3 | >600Â ng/ml | 3/3 | >600Â ng/ml |
100 nM | 3/3 | >600Â ng/ml | 3/3 | >600Â ng/ml |
- MT2 cells were infected by pseudotyped G367R viruses at 4-fold dilutions and grown in the presence of entry inhibitors. The cultures were then split into 2 wells at day 7 with only one of them being maintained in the presence of inhibitors.
- aContinuous represents the maintainance of the entry inhibitors in the cultures. Withdrawal represents drug withdrawal after 7Â days of infection.
- bCPE = cytopathic effect.
- cNumbers of samples in which CPE was observed over 5Â weeks after infection.
- devaluated during 28Â days following infection. p24 values of CPE negative samples were lower than listed.